Evidence map›Paper›PMID 40238876›Full record

ArticleScience advances2025

Persistent IgG1 clones dominate and personalize the plasma antibody repertoire.

Danique M H van Rijswijck, Albert Bondt, Dina Raafat, Silva Holtfreter, Kilian A Wietschel, Sjors P A van der Lans, Uwe Völker, Barbara M Bröker, Albert J R Heck

Abstract read
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Extending Serum IgG1 Antibody Repertoire Coverage Using DIA-PTCR.Journal of the American Society for Mass Spectrometry · 2026
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Danique M H van RijswijckBiomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Padualaan 8, Utrecht 3584 CH, Netherlands.ORCID 0000-0003-1377-9992
Albert BondtBiomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Padualaan 8, Utrecht 3584 CH, Netherlands.ORCID 0000-0002-0985-7903
Dina RaafatInstitute of Immunology, University Medicine Greifswald, Greifswald, Germany.ORCID 0000-0002-3610-9863
Silva HoltfreterInstitute of Immunology, University Medicine Greifswald, Greifswald, Germany.ORCID 0000-0002-2672-8230
Kilian A WietschelInstitute of Immunology, University Medicine Greifswald, Greifswald, Germany.ORCID 0000-0003-4026-1785
Sjors P A van der LansDepartment of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Uwe VölkerDepartment of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, 17475, Germany.ORCID 0000-0002-5689-3448
Barbara M BrökerInstitute of Immunology, University Medicine Greifswald, Greifswald, Germany.ORCID 0000-0002-5020-8542
Albert J R HeckBiomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Padualaan 8, Utrecht 3584 CH, Netherlands.ORCID 0000-0002-2405-4404

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibodies play a pivotal role in the immune defense and long-term immunity. Yet, while several studies have highlighted the persistence of antigen-specific antibody responses, it is unclear whether this stems from the continuous production of the same clones or recurrent activation of B cells generating new clones. To examine the stability of the human antibody repertoire, we monitored the concentrations of the most abundant IgG1 clones in plasma samples of 11 healthy donors at nine sampling points over a year. During this year, each donor received three doses of a COVID-19 vaccine. Notwithstanding these vaccinations, the concentrations of the most abundant IgG1 clones remained constant. Given the 2- to 3-week half-life of IgG1 molecules in blood, our data suggest that these clones are associated with long-term immunity and do not undergo somatic hypermutation which would imply short-lived plasma cells. Overall, our data suggest that most of the abundant IgG1 clones in plasma are persistently produced by long-lived plasma cells.

Indexed as

Antibodies, ViralCOVID-19Immunoglobulin GAdultB-LymphocytesClone CellsCOVID-19 VaccinesFemaleHumansMalePlasma CellsSARS-CoV-2Antibodies, ViralCOVID-19 VaccinesImmunoglobulin G

Identifiers

PMID40238876
PMCPMC12002106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.